Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.8238
-0.0053 (-0.63%)
Apr 25, 2025, 11:33 AM EDT - Market open
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $7.31 million as of April 25, 2025. Its market cap has decreased by -27.46% in one year.
Market Cap
7.31M
Enterprise Value
6.37M
1-Year Change
-27.46%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $7.31M, a decrease of -79.28%. That is a compound annual growth rate of -36.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 7.06M | -16.47% |
| Dec 31, 2024 | 8.45M | 100.93% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.17B |
| UnitedHealth Group | 387.16B |
| Johnson & Johnson | 379.07B |
| AbbVie | 306.72B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.13B |
| AstraZeneca | 210.34B |
| Novartis AG | 209.93B |